Ajanta Pharma Ltd.

Financial

	Ajanta Pharma	Gland Pharma	Ipca Laboratories
Operational Metrics
Pharmaceutical Sector
Number of ANDA's Filed in USA	76.0 .	371.0 .	44.0 .
Number of ANDA's Approved By USFDA	55.0 .	318.0 .	31.0 .
Domestic Sales Growth - YoY	7.5 %	n/a	8.3 %
R&D as a % of Total Sales	4.0 %	4.9 %	3.12 %
Financials
5 yr Average ROE	21.63 %	12.02 %	13.55 %
5yr average Equity Multiplier	1.32	1.15	1.52
5yr Average Asset Turnover Ratio	0.84	0.51	0.76
5yr Avg Net Profit Margin	19.77 %	20.79 %	11.88 %
Price to Book	9.07	3.72	5.38
P/E	36.96	48.72	50.67
5yr Avg Cash Conversion Cycle	-102.34 Days	69.81 Days	54.3 Days
Inventory Days	55.16 Days	118.26 Days	102.83 Days
Days Receivable	49.8 Days	99.92 Days	72.68 Days
Days Payable	195.69 Days	107.43 Days	111.38 Days
5yr Average Interest Coverage Ratio	108.5	183.05	50.79
5yr Avg ROCE	27.48 %	16.55 %	17.31 %
5yr Avg Operating Profit Margin	27.65 %	29.26 %	19.8 %
5 yr average Debt to Equity	0.0	0.01	0.17
5yr CAGR Net Profit	7.08 %	-6.87 %	-8.34 %
5yr Average Return on Assets	16.51 %	10.65 %	9.41 %
Shareholdings
Promoter Holding	66.26 %	51.83 %	44.72 %
Share Pledged by Promoters	14.12 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	-4.22 %	-6.04 %	-1.57 %
Change in Mutual Fund Holding (3 Yrs)	3.84 %	15.13 %	0.2 %

Business

	Ajanta Pharma	Gland Pharma	Ipca Laboratories
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Injectables 0 Pharmaceuticals 0 API 0 Generics 0 Branded Generics 0	Product Wise Break-Up Pharmaceutical 0 Injectables 0 Generics 0 Pharmaceutical 100.0 API 0 Branded Generics 0	Product Wise Break-Up Pharmaceutical 0 Injectables 0 Formulations 33.08 Pharmaceuticals 0 Active Pharmaceutical Ingredient (API) 16.53 Branded Generics 50.39
Segment Break-Up	Segment Break-Up Others 100	-	-
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Dermatology 23.0 Pain 10.0 Neutraceuticals 0 Urology 0 Cough Preparations 0 Neuro Psychiatry 0 Gastro-Intestinal (GI) Products 0 Anti-Bacterials 0 Anti-Malarials 0 Cardiovasculars & Anti-Diabetics 0 0 Others 67.0	-	Therapeutic Area Wise Break-Up - Domestic Cardiac Science 17.0 Anti Malarials 3.0 Anti-bacterial 5.0 0 Neutraceuticals 1.0 Cough and colds 4.0 Gastro Intestinal 2.0 Urology 5.0 Pain 53.0 Dermatology 6.0 Central Nervous System (CNS) 3.0 Others 1.0
Location Wise Break-Up	Location Wise Break-Up India 31.73 USA 24.05 Asia Pacific 23.58 Africa 20.64 Canada, Australia & New Zealand 0 Australia 0 Canada 0 Europe 0 Asia (Excluding India) 0 CIS 0	Location Wise Break-Up USA 55.57 Asia (Excluding India) 0 Australia 0 India 3.68 Africa 0 Canada 0 CIS 0 Asia Pacific 0 Europe 19.66 Canada, Australia & New Zealand 4.22 Others 16.87	Location Wise Break-Up USA 21.58 Asia Pacific 5.18 Australia 3.2 India 44.73 Africa 6.72 Canada 0 CIS 2.91 Asia Pacific 0 Europe 15.68 Canada, Australia & New Zealand 0
Asset Break-Up	Asset Break-Up India 98.73 USA 0.66 Asia Pacific 0.4 Africa 0.21	-	-

Ajanta Pharma Ltd.

SIGN UP FOR FREE